William L Baker

Summary

Affiliation: Hartford Hospital
Country: USA

Publications

  1. ncbi Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis
    William L Baker
    School of Pharmacy, University of Connecticut, Storrs, and Division of Cardiology, Hartford Hospital 06102, USA
    Am J Health Syst Pharm 64:830-6. 2007
  2. ncbi Probable enoxaparin-induced hepatotoxicity
    Erica L Baker
    Evidence Based Practice Center, Hartford Hospital, Hartford, CT, USA
    Am J Health Syst Pharm 66:638-41. 2009
  3. ncbi The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literature
    William L Baker
    Evidence-based Practice Center, Hartford Hospital, USA
    Conn Med 72:465-8. 2008
  4. ncbi Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes
    William L Baker
    Evidence Based Practice Center, Hartford Hospital, Hartford, Connecticut 06102 5037, USA
    Am J Cardiovasc Drugs 9:213-29. 2009
  5. ncbi Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease
    William L Baker
    University of Connecticut Hartford Hospital Evidence Based Practice Center, 80 Seymour Street, Hartford, CT 06102, USA
    Ann Intern Med 151:861-71. 2009
  6. ncbi Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Diabetes Res Clin Pract 87:98-107. 2010
  7. ncbi The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis
    Jennifer M Scholle
    University of Connecticut School of Pharmacy, and Director, Pharmacoeconomics and Outcomes Studies Group, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102 5037, USA
    J Am Coll Nutr 28:517-24. 2009
  8. ncbi Association between CHADS?risk factors and anticoagulation-related bleeding: a systematic literature review
    Wendy T Chen
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Mayo Clin Proc 86:509-21. 2011
  9. ncbi The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis
    William L Baker
    The Evidence Based Practice Center, Hartford Hospital, Hartford, CT 06102 5037, United States
    Diabetes Res Clin Pract 84:e33-7. 2009
  10. ncbi The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III
    Nitesh Sood
    Division of Cardiology, Hartford Hospital, Hartford, CT 06102, USA
    J Cardiothorac Vasc Anesth 23:22-7. 2009

Collaborators

  • Craig I Coleman
  • William B White
  • Dee Silver
  • Diana M Sobieraj
  • D M Murray
  • C Michael White
  • Olivia J Phung
  • Nitesh Sood
  • Ripple Talati
  • Jeffrey Kluger
  • Wendy T Chen
  • Stephen D Bendel
  • Jennifer M Scholle
  • Kurt M Reinhart
  • Erica L Baker
  • Patrick Campbell
  • Jennifer A Colby
  • Joshua D Courter
  • Elisa Saranitzky
  • Effie L Kuti
  • Erika L Baker
  • Olivia P Phung
  • Ajibade Ashaye
  • Ajibade O Ashaye
  • Kurt Reinhart
  • Robert Bona
  • Vanita Tongbram
  • Sagar Makanji
  • Robert A Quercia
  • Jennifer L Bell
  • Alicia Thorne
  • Michael Lanosa
  • Lindsey L Desjardins
  • Katherine S Nowak
  • Lori A Smogowicz
  • Kevin Keating
  • Jennifer E Girotto
  • Leslie J Matthews
  • Arun Padala
  • Mary S Pabilonia
  • Edward Salerno
  • Theodore Loewenthal

Detail Information

Publications41

  1. ncbi Azithromycin for the secondary prevention of coronary artery disease: a meta-analysis
    William L Baker
    School of Pharmacy, University of Connecticut, Storrs, and Division of Cardiology, Hartford Hospital 06102, USA
    Am J Health Syst Pharm 64:830-6. 2007
    ..A meta-analysis of randomized, controlled trials that evaluated the effect of the macrolide antibiotic, azithromycin, on clinical outcomes in patients with coronary artery disease (CAD) was conducted...
  2. ncbi Probable enoxaparin-induced hepatotoxicity
    Erica L Baker
    Evidence Based Practice Center, Hartford Hospital, Hartford, CT, USA
    Am J Health Syst Pharm 66:638-41. 2009
    ..A case of probable enoxaparin-induced hepatotoxicity is described...
  3. ncbi The role of soluble fiber in the management of patients with hypercholesterolemia: a review of the literature
    William L Baker
    Evidence-based Practice Center, Hartford Hospital, USA
    Conn Med 72:465-8. 2008
  4. ncbi Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes
    William L Baker
    Evidence Based Practice Center, Hartford Hospital, Hartford, Connecticut 06102 5037, USA
    Am J Cardiovasc Drugs 9:213-29. 2009
    ....
  5. ncbi Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease
    William L Baker
    University of Connecticut Hartford Hospital Evidence Based Practice Center, 80 Seymour Street, Hartford, CT 06102, USA
    Ann Intern Med 151:861-71. 2009
    ..Patients with ischemic heart disease and preserved ventricular function experience considerable morbidity and mortality despite standard medical therapy...
  6. ncbi Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Diabetes Res Clin Pract 87:98-107. 2010
    ..To determine whether individual statins had differing effects on insulin sensitivity (IS) in patients without pre-existing diabetes mellitus...
  7. ncbi The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis
    Jennifer M Scholle
    University of Connecticut School of Pharmacy, and Director, Pharmacoeconomics and Outcomes Studies Group, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102 5037, USA
    J Am Coll Nutr 28:517-24. 2009
    ..To characterize the effect of plant sterols/stanols on serum lipids in hypercholesterolemic patients on concurrent statin therapy, we conducted a meta-analysis of randomized controlled trials...
  8. ncbi Association between CHADS?risk factors and anticoagulation-related bleeding: a systematic literature review
    Wendy T Chen
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Mayo Clin Proc 86:509-21. 2011
    ....
  9. ncbi The effect of plant sterols or stanols on lipid parameters in patients with type 2 diabetes: a meta-analysis
    William L Baker
    The Evidence Based Practice Center, Hartford Hospital, Hartford, CT 06102 5037, United States
    Diabetes Res Clin Pract 84:e33-7. 2009
    ..Upon meta-analysis, plant sterols/stanols significantly reduced total and LDL cholesterol, with a trend towards improvement in HDL. No beneficial effect on triglycerides was apparent...
  10. ncbi The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III
    Nitesh Sood
    Division of Cardiology, Hartford Hospital, Hartford, CT 06102, USA
    J Cardiothorac Vasc Anesth 23:22-7. 2009
    ..To evaluate the impact of postoperative red blood cell transfusions and white blood cell (WBC) counts on post-cardiothoracic surgery atrial fibrillation...
  11. ncbi Effect of ascorbic acid on inflammatory markers after cardiothoracic surgery
    Jennifer A Colby
    Hartford Hospital, CT 06102, USA
    Am J Health Syst Pharm 68:1632-9. 2011
    ..The effect of ascorbic acid on inflammatory markers after cardiothoracic surgery (CTS) was studied...
  12. ncbi The effects of barley-derived soluble fiber on serum lipids
    Ripple Talati
    University of Connecticut School of Pharmacy, Storrs, Connecticut, USA
    Ann Fam Med 7:157-63. 2009
    ..We wanted to determine the association between consumption of barley and changes in plasma lipids in healthy and hypercholesterolemic men and women...
  13. ncbi Combination therapy for the management of hypertension: A review of the evidence
    Nitesh Sood
    Department of Cardiology, Hartford Hospital, CT, USA
    Am J Health Syst Pharm 67:885-94. 2010
    ..Evidence regarding combination therapy for the management of hypertension is reviewed...
  14. ncbi A meta-analysis evaluating the impact of chitosan on serum lipids in hypercholesterolemic patients
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Ann Nutr Metab 55:368-74. 2009
    ..To better characterize the impact of chitosan on serum lipids in hypercholesterolemic patients, we performed a meta-analysis of randomized controlled trials...
  15. ncbi Efficacy and Safety of Innovator versus Generic Drugs in Patients with Epilepsy: A Systematic Review
    Ripple Talati
    From the University of Connecticut Hartford Hospital, Evidence Based Practice Center, Hartford, Connecticut
    Pharmacotherapy 32:314-22. 2012
    ....
  16. ncbi Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis
    William L Baker
    Hartford Hospital Drug Information Center, Hartford, Connecticut 06102 5037, USA
    Pharmacotherapy 29:891-905. 2009
    ..To assess the comparative efficacy of pharmacologic agents for the maintenance treatment of chronic obstructive pulmonary disease (COPD)...
  17. ncbi Improved glucose control associated with i.v. chromium administration in two patients receiving enteral nutrition
    Olivia J Phung
    University of Connecticut UC Hartford Hospital HH Evidence Based Practice Center, Hartford, CT 06102 5037, USA
    Am J Health Syst Pharm 67:535-41. 2010
    ..The effect of i.v. chromium administration on glucose control in two patients receiving enteral nutrition is described...
  18. ncbi Effect of magnesium L-lactate on blood pressure in patients with an implantable cardioverter defibrillator
    William L Baker
    Evidence Based Practice Center, Hartford, CT, USA
    Ann Pharmacother 43:569-76. 2009
    ..Previous studies have evaluated the impact of oral magnesium on blood pressure; however, they used magnesium salts with low bioavailability, had methodological issues, and showed differing results...
  19. ncbi Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials
    Craig I Coleman
    University of Connecticut, School of Pharmacy, Hartford, Connecticut 06102 5037, USA
    J Hypertens 26:622-9. 2008
    ..The aim of this article is to determine the association between commonly used antihypertensive agents and the incidence of cancer...
  20. ncbi Intravenous hydralazine for blood pressure management in the hospitalized patient: its use is often unjustified
    Patrick Campbell
    Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, Farmington, CT, USA
    J Am Soc Hypertens 5:473-7. 2011
    ..Thus, this agent may not be useful for treating hypertension in many hospitalized patients and may cause harm if used inappropriately...
  21. ncbi Effect of cinnamon on glucose control and lipid parameters
    William L Baker
    Department of Pharmacy Practice, School of Pharmacy, University of Connecticut, Storrs, Connecticut, USA
    Diabetes Care 31:41-3. 2008
    ..To perform a meta-analysis of randomized controlled trials of cinnamon to better characterize its impact on glucose and plasma lipids...
  22. ncbi Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis
    Olivia J Phung
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Am J Clin Nutr 91:73-81. 2010
    ..Green tea catechins (GTCs) with or without caffeine have been studied in randomized controlled trials (RCTs) for their effect on anthropometric measures and have yielded conflicting results...
  23. ncbi Prasugrel: a critical comparison with clopidogrel
    Kurt M Reinhart
    Department of Pharmacy, Hartford Hospital, Hartford, Connecticut 06102, USA
    Pharmacotherapy 29:1441-51. 2009
    ..Given the totality of data available, prasugrel appears to be a promising treatment option for patients with acute coronary syndromes who are undergoing percutaneous coronary interventions...
  24. ncbi Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis
    William L Baker
    School of Pharmacy, University of Connecticut, CT, USA
    Parkinsonism Relat Disord 15:287-94. 2009
    ....
  25. ncbi Feverfew for migraine prophylaxis: a systematic review
    Elisa Saranitzky
    University of Connecticut, School of Pharmacy, Storrs, Connecticut, USA
    J Diet Suppl 6:91-103. 2009
    ..Pharmacologically, there is some potential for concern with long-term dosing given its cyclooxygenase-2 inhibiting effects and longer-term studies will be needed to ameliorate these concerns in coronary disease patients...
  26. ncbi The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker
    Effie L Kuti
    School of Pharmacy, University of Connecticut, Storrs, CT, USA
    Curr Med Res Opin 23:1239-44. 2007
    ..Pharmacologic data has shown improved insulin sensitivity with ACEIs and ARBs. Controversy persists regarding the influence of calcium channel blockers on the development of new-onset diabetes...
  27. ncbi Effect of nonergot dopamine agonists on symptoms of restless legs syndrome
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, Connecticut, USA
    Ann Fam Med 6:253-62. 2008
    ..We performed a meta-analysis of randomized placebo-controlled trials of nonergot dopamine agonists (NEDAs) for the treatment of restless legs syndrome...
  28. ncbi Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis
    Nitesh Sood
    University of Connecticut Schools of Medicine and Drug Information, Hartford Hospital, Hartford, CT 06102 5037, USA
    Am J Clin Nutr 88:1167-75. 2008
    ..Several clinical trials have investigated the impact of glucomannan on plasma lipids, body weight, fasting blood glucose (FBG), and blood pressure (BP), but have yielded conflicting results and had only modest sample sizes...
  29. ncbi Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, CT, USA
    Eur J Cardiothorac Surg 35:521-7. 2009
    ..Currently, the most compelling data for using NAC in CTS patients is in post-CTS AF prevention. However, additional, larger randomized controlled trials evaluating this and other postoperative complication endpoints are needed...
  30. ncbi Assessing the usefulness of health-related quality-of-life trials: a clinician's perspective using two COPD examples
    Olivia J Phung
    University of Connecticut Hartford Hospital Evidence Based Practice Center, Hartford, CT 06102, USA
    Ann Pharmacother 43:1496-505. 2009
    ..To empower clinicians to discern when health-related quality-of-life (HRQoL) evidence from a single trial, or from constituent trials within a systematic review or meta-analysis, is compelling enough to alter clinical practice...
  31. ncbi Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States
    William L Baker
    University of Connecticut Hartford Hospital Evidence Based Practice Center, Hartford, CT 06102, USA
    J Manag Care Pharm 15:244-52. 2009
    ....
  32. ncbi Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation
    Stephen D Bendel
    Schools of Pharmacy and Medicine, Storrs and Farmington CT and Department of Hematology Oncology, University of Connecticut, Farmington, USA
    Adv Ther 28:460-72. 2011
    ..Dabigatran offers a unique alternative to warfarin in patients with nonvalvular AF and can be beneficial in patients requiring anticoagulation therapy...
  33. ncbi Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay
    William L Baker
    University of Connecticut School of Pharmacy, Storrs, Connecticut, USA
    Heart Rhythm 4:461-8. 2007
    ..Corticosteroids have been traditionally used to reduce inflammation, and when administered perioperatively, they may decrease the incidence of atrial fibrillation...
  34. ncbi Renin-angiotensin system inhibitors for prevention of new-onset atrial fibrillation
    William L Baker
    University of Connecticut School of Pharmacy, Division of Cardiology and Drug Information, Hartford Hosptial, Hartford, USA
    Conn Med 71:205-9. 2007
  35. ncbi Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis
    Joshua D Courter
    Connecticut Children s Medical Center, Hartford, CT 06106, USA
    Ann Pharmacother 44:471-8. 2010
    ....
  36. ncbi Azilsartan medoxomil: a new angiotensin II receptor antagonist for treatment of hypertension
    William L Baker
    School of Pharmacy, University of Connecticut, Farmington, CT, USA
    Ann Pharmacother 45:1506-15. 2011
    ....
  37. ncbi Pitavastatin: a new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia
    William L Baker
    Schools of Pharmacy and Medicine, University of Connecticut, 263 Farmington Ave, MC2205, Storrs and Farmington, CT 06030, USA
    Adv Ther 28:13-27. 2011
    ....
  38. ncbi Post-cardiothoracic surgery atrial fibrillation: a review of preventive strategies
    William L Baker
    School of Pharmacy, University of Connecticut, Hartford, CT, USA
    Ann Pharmacother 41:587-98. 2007
    ..To review the available literature addressing preventive strategies of post-cardiothoracic surgery atrial fibrillation (post-CTS atrial fibrillation)...
  39. ncbi Cardiovascular effects of migraine therapy
    William L Baker
    Department of Pharmacy Practice, UCONN School of Pharmacy, Hartford, CT 0615, USA
    Prog Cardiovasc Nurs 18:151-7,161. 2003
  40. ncbi Sizing a trial to alter the trajectory of health behaviours: methods, parameter estimates, and their application
    David M Murray
    Division of Epidemiology, School of Public Health, The Ohio State University, B222 Starling Loving Hall, 320 West 10th Street, Columbus, OH 43210, USA
    Stat Med 26:2297-316. 2007
    ..We provide estimates for the parameters required for those calculations for a number of adolescent health behaviours. We also show how the estimates can be used to plan a future trial...
  41. ncbi A comparison of permutation and mixed-model regression methods for the analysis of simulated data in the context of a group-randomized trial
    David M Murray
    Department of Psychology, The University of Memphis, TN 38152 3230, USA
    Stat Med 25:375-88. 2006
    ..Binomial group- and member-level errors did not otherwise change the relative performance of the two methods with regard to confounding...